Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
25.80
-0.40 (-1.53%)
Nov 18, 2026, 12:56 PM EST - Market open
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $1.87 billion as of November 18, 2026. It is the 6,606th most valuable company in the world and the 1,756th biggest in the United States. Its market cap has decreased by 0.96% in one year.
Market Cap
1.87B
Enterprise Value
1.56B
1-Year Change
-0.96%
Global Rank
Country Rank
#1,756 United States
Category
ChartMarket Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $1.87B, an increase of 728.02%. That is a compound annual growth rate of 46.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.87B | -48.11% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 2.06B |
| Replimune Group | 2.02B |
| First Tracks Biotherapeutics | 1.95B |
| Septerna | 1.95B |
| Harmony Biosciences Holdings | 1.93B |
| Maravai LifeSciences Holdings | 1.93B |
| Fortrea Holdings | 1.90B |
| Trevi Therapeutics | 1.88B |